Approval · Notice of Compliance 28208 · 2022
LUMIFY: Notice of Compliance 28208
Issued May 19, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28208
- Date
- May 19, 2022
- Company
- Bausch & Lomb Inc.Rochester, New York, United States
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LUMIFY | Not yet assigned | — |
Medicinal ingredients
- BRIMONIDINE TARTRATE 0.25 MG per ML